In Vivo Treatment With Blocking Antibody to IL-2 in C57Bl/6 Mice Infected With the Tulahuen Strain of T. cruzi Resulted in Lower Parasitemia and Higher Survival Rates. Here, IL2 is linked to parasitic infectious disease.